ADAM HELME DE HAVENON portrait
  • Adjunct Associate Professor, Neurology
  • Assistant Professor, Neurology
801-585-7575

Presentations

  • de Havenon A, Wang H, Stoddard G, Chung L, Majersik J. Increased Blood Pressure Variability is Associated with Worse Outcome in Acute Ischemic Stroke. Oral Presentation, Stroke Council Award session, American Heart Association, Scientific Sessions, 2015. , , 2016.
  • de Havenon, A, Collateral Imaging: Clinical and Translational Roadmap. 3rd International Symposium on Collaterals to the Brain, University of California Los Angeles, CA. , , 2016.
  • de Havenon, A, Cryptogenic Stroke. Neurohospitalist Society Annual Meeting, UT. , , 2016.
  • de Havenon, A, Ultrasound in Cerebrovascular Disease. Utah Stroke Symposium, UT. , , 2016.
  • de Havenon A. “The Presentation of Acute Stroke.” Annual Neuroscience Nursing Symposium, University of Washington, Seattle, WA, 2014. , , 2014.
  • de Havenon A, Petersen C, Sultan-Qurraie A, Hoesch R. Virtual Family Meetings in the ICU Setting: Results from an Audiovisual Conferencing Intervention. Oral Presentation, American Academy of Neurology Annual Meeting, 2014. , , 2014.
  • Diabetic Retinopathy and Risk of Stroke: A Secondary Analysis of Accord Senior Author. International Stroke Conference. , Presented, 2020.
  • White Matter Hyperintensity and Cardiovascular Disease Outcomes: A Secondary Analysis of the SPRINT MIND Trial. International Stroke Conference. , Presented, 2020.
  • Optimizing Outcome Prediction After Supratentorial Intracerebral Hemorrage: A Secondary Analysis of ATACH 2, CLEAR III, and MISTIE III. International Stroke Conference. , Presented, 2020.
  • Using Ultrasound and Inflammation to Improve Prediction of Ischemic Stroke: A Secondary Analysis of MESA. International Stroke Conference. , Presented, 2020.
  • Association of White Matter Hyperintensity Progression and Cognitive Decline: A Secondary Analysis of the ACCORDION MIND Study. International Stroke Conference. , Presented, 2020.
  • Relationship Between Preeclampsia and Subsequent Stroke: A Secondary Analysis of the Framingham Heart Study. International Stroke Conference. , Presented, 2020.
  • Quality of Life for Younger Patients Following Lacunar Stroke: A Secondary Analysis of SPS-3. , Presented, 2020.
  • Increased Blood Pressure Variability After Acute Ischemic Stroke Increases the Risk of Death. International Stroke Conference. , Presented, 2019.
  • Predictors of Increased Blood Pressure Variability after Intracerebral Hemorrhage. International Stroke Conference. , Presented, 2019.
  • Carotid Artery Stiffness and the Development of White Matter Hyperintensities over a 20-Year Period. International Stroke Conference. , Presented, 2019.
  • ASPECTS Derived from CTA Source Images Better Predicts CT Perfusion Lesion Core Volume, Target Mismatch, and Good Clinical Outcome. American Society of Neuroradiology Annual Meeting,. , Presented, 2019.
  • Risk of Recurrent Stroke by Fazekas Category and Relationship with Intensive Blood Pressure Reduction. International Stroke Conference. , Presented, 2019.
  • Results From the DEFUSE 3 Trial: Good Leptomeningeal Collaterals Are Associated With Reduced Core Infarct Size but Not Improved Neurologic Outcome. International Stroke Conference. , Presented, 2019.
  • Systolic Blood Pressure and White Matter Hyperintensity Progression in ACCORD-MIND. International Stroke Conference. , Presented, 2018.
  • Predictors of Ischemic Stroke and Stroke Mimic During Pregnancy. International Stroke Conerence. , Presented, 2018.
  • de Havenon, A, Etiology of Late Right-to-Letft Shunting on Transcranial Doppler in Ischemic Stroke Patients. Oral Presentation, International Stroke Conference. , , 2017.
  • de Havenon, A, Determinants of Intracranial Atherosclerotic Enhancement on Vessel Wall MRI in Patients with Acute Ischemic Stroke. Oral Presentation, International Stroke Conference. , , 2017.
  • de Havenon A, Stoddard G, Wang H, Chung L, Majersik J. Increased blood pressure variability is associated with worse outcome in acute ischemic stroke patients with penumbra. European Stroke Conference, Oral Presentation. Vienna, Austria; 2015. , , 2015.
  • de Havenon A. The Ischemic Penumbra, Collateral Blood Vessels, and Implications for Stroke Prognosis. Utah Stroke Symposium 2015. , , 2015.
  • Sultan-Qurraie A., de Havenon A., et al. Younger Age and Anticoagulation Are Risk Factors For Pseudoaneurysm In Cases of Cervical Arterial Dissection. International Stroke Conference, 2015. , , 2015.
  • de Havenon A., Tirschwell D.L., Sultan-Qurraie A., Jalal A. Arterial Spin Labeling MRI Identifies Ischemic Stroke Patients with Good Outcome at Hospital Discharge. International Stroke Conference, 2015. , , 2015.
  • de Havenon A., Tirschwell D.L., Sultan-Qurraie A., Mossa-Basha M. High-risk features on carotid MRI do not corelate with emboli monitoring on TCD. American Society of Neuroimaging Annual Meeting, 2015. , , 2015.
  • Mossa-Basha M, ... de Havenon A, et al. "The value of high-resolution vessel wall MR imaging for the differentiation of intracranial vasculopathies". Radiological Society of North America Annual Meeting, Chicago, Illinois. , , 2014.
  • de Havenon A, Tirschwell D, Andre J. "Medial occipital lobe hyperperfusion - a poor prognostic sign for patients with hypoxic-anoxic injury." Radiologic Society of North America Annual Meeting, Chicago, Illinois. , , 2014.
  • de Havenon A, Sultan-Qurraie A, Moore A, Tirschwell D. "A Comparison of Transcranial Doppler to Echocardiography for the Detection of Right-to-left Shunt in Ischemic Stroke Patients." European Stroke Conference, Nice, France. , , 2014.
  • de Havenon A, Petersen C, Sultan-Qurraie A, Hoesch R. "Virtual Family Meetings in the ICU Setting: Results from an Audiovisual Conferencing Intervention." Platform presentation American Academy of Neurology Annual Meeting, Philadelphia, PA. , , 2014.
  • Sultan-Qurraie A, de Havenon A, Tirschwell DL et al. "Performance Metrics for The Interventional Treatment Of Acute Ischemic Stroke: Results from A Comprehensive Stroke Center." American Academy of Neurology Annual Meeting, Philadelphia, PA. , , 2014.
  • Longenecker L, Shah L, de Havenon A et al. "Two Case Reports of Posterior Reversible Encephalopathy Syndrome (PRES) Involving the Spinal Cord." American Society of Spine Radiology Annual Symposium, Miami, FL. , , 2014.
  • Sultan-Qurraie S, de Havenon A, Becker K et al. "Improved Ischemic Stroke Outcomes After Intra-arterial Interventions Associated with Higher HDL Cholesterol." International Stroke Conference, San Diego, California. , , 2014.
  • de Havenon A, Joos Z, Longenecker L. "A Hypertensive Reversible Encephalomyelitis Syndrome (HyRES)." International Stroke Conference, San Diego, California. , , 2014.
  • de Havenon A, Hoesch B. "Audiovisual Conferencing in the ICU." American Academy of Neurology, Annual Meeting. , , 2012.
  • de Havenon A, Ehrenkranz J. "Perforated Diverticulum in Patients with Cushing’s Disease." Endocrine Society Annual Meeting. , , 2011.
  • de Havenon A, Miller, R. "Rhinovirus Lower Respiratory Tract Infection in the ICU Setting." Society of Critical Care Medicine, Annual Meeting. , , 2011.
  • de Havenon A. "Missing the Diagnosis." American College of Physicians Annual Meeting, Utah Chapter. , , 2009.

Languages

  • English, Fluent.
  • Spanish, Fluent.

Publications

  • de Havenon A, O’Donnell S, Linn A, McNally S, Dunleavy B, Majersik J (date unknown). A Simple Tool to Predict Target Mismatch in Ischemic Stroke Patients with Anterior Circulation Occlusion. Moderated Poster. Accepted, .
  • Linn AJ, O’Donnell S, de Havenon A (date unknown). Comparison of Two Methods of the Alberta Stroke Program Early CT Score. Poster. Accepted, .
  • O’Donnell S, Linn A, Majersik J, Wang H, Chung L, de Havenon A (date unknown). Computed Tomography Angiography is Better at Predicting Lesion Core Volume in Acute Ischemic Stroke Patients with Proximal Occlusion. Poster. Accepted, .
  • de Havenon A, Lobo R, Eisenmenger L, Chauhan N, Dewitt D, Kim S-E, et al (date unknown). MRI Detection of Vessel Wall Inflammation and Contrast Leakage in Cerebral Amyloid Angiopathy. Poster. Accepted, .
  • de Havenon A, O’Donnell S, Wang H, Smith G, Majersik J (date unknown). A Comparison of Three Different CTA Collateral Scoring Systems’ Ability to Predict MR Lesion Volume and Outcome After Ischemic Stroke. E-Poster. Accepted, .
  • Bennett A, de Havenon A, Wilder M, Sultan-Qurraie A, Ansari S (date unknown). Determinants of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Patients after Endovascular Therapy. Poster. Accepted, .
  • Bennett A, Wilder M, Majersik J, Ansari S, de Havenon A (date unknown). Increased Systolic Blood Pressure Variability is Associated with Symptomatic Intracerebral Hemorrhage after Endovascular Treatment for Stroke. Moderated poster session. Accepted, .
  • Donleavy B, Chung L, Smith G, Majersik J, de Havenon A (date unknown). A Comparison Of Automated And Manual Volumetric Analysis Of Ct Perfusion In Acute Ischemic Stroke Patients. Poster. Accepted, .
  • O’Donnell S, Majersik J, Smith G, Dunleavy B, de Havenon A (date unknown). CT-Based Collateral Scoring Can Predict Ischemic Penumbra Volume in Acute Ischemic Stroke. Poster. Accepted, .
  • Bennett A, Aitken K, Longbottom M, Brown R, de Havenon A, Majersik J, Robb D (date unknown). American Indian Participation in Clinical Research: A Cultural Perspective Survey from a CREST-2 Site. Poster. Accepted, .
  • Bennett A, Wilder M, Majersik J, Ansari A, de Havenon A (date unknown). Increased Systolic Blood Pressure Variability is Associated with Symptomatic Intracerebral Hemorrhage After Endovascular Treatment for Stroke. Poster. Accepted, .
  • Dunleavy B, Chung L, Wang H, Majersik J, de Havenon A (date unknown). A Comparison of Automated and Manual Volumetric Analysis of CT Perfusion in Acute Ischemic Stroke Patients. Poster. Accepted, .
  • Robb D, de Havenon A, Bennett A, Aitken K, Longbottom M, Brown R, MajersikJ (date unknown). American Indian Participation in Clinical Research: A Cultural Perspective Survey from a CREST-2 Site. Poster. Accepted, .
  • Bennett A, de Havenon A, Wilder M, Sultan-Qurraie A, Ansari A (date unknown). Determinants of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Patients After Endovascular Therapy. Moderated Poster. Accepted, .
  • de Havenon A, Tirschwell DL, Chung L, Wang H, Smith G, Majersik J (date unknown). Prediction of Neurologic Outcome after Ischemic Stroke with Volumetric Measurements on CT and MRI. Poster. Accepted, .
  • Sultan-Qurraie A, de Havenon A, Lynch J, Fred-Fitzsimmons B (date unknown). Early Platelet Transfusion in Pateints with Subarachnoid Hemorrhage Does Not Improve Outcome. Poster. Accepted, .
  • de Havenon A, Parker D, Kim S, Park M, McNally S (date unknown). Intracranial High-Resolution Vessel Wall MRI for the Detection of Arterial Inflammation, Unraveling Vascular Inflammation: From Inflammation to Imaging. Accepted, .
  • de Havenon A, Tirschwell DL, Sultan-Qurraie A, Jalal A (date unknown). Arterial Spin Labeling MRI Identifies Ischemic Stroke Patients with Good Outcome at Hospital Discharge. Poster. Accepted, .
  • de Havenon A, Tirschwell DL, Anzai Y et al (date unknown). Medial occipital lobe hyperperfusion – a poor prognostic sign for patients with hypoxic-anoxic injury. Poster. Accepted, .
  • Mossa-Basha M, Ferndale M, Hwang W, Hatsukami T, de Havenon A et al (date unknown). The Value of High-Resolution T2-Weighted Vessel Wall MR Imaging for the Differentiation of Intracranial Vasculopathies. Oral abstract. Accepted, .
  • de Havenon A, Sultan-Qurraie A, Moore A, Tirschwell D (date unknown). A Comparison of Transcranial Doppler to Echocardiography for the Detection of Right-to-left Shunt in Ischemic Stroke Patients. Poster. Accepted, .
  • Sultan-Qurraie A, de Havenon A, Tirschwell DL et al (date unknown). Performance Metrics for The Interventional Treatment Of Acute Ischemic Stroke: Results from A Comprehensive Stroke Center. Moderated poster. Accepted, .
  • Longenecker L, de Havenon A, Joos Z et al (date unknown). Two Case Reports of Posterior Reversible Encephalopathy Syndrome (PRES) Involving the Spinal Cord. Oral presentation. Accepted, .
  • de Havenon A, Joos Z, Longenecker L et al (date unknown). A Hypertensive Reversible Encephalomyelitis Syndrome (HyRES). Poster. Accepted, .
  • Sultan-Qurraie S, de Havenon A, Becker K et al (date unknown). Improved Ischemic Stroke Outcomes After Intra-arterial Interventions Associated with Higher HDL Cholesterol. Poster. Accepted, .
  • de Havenon A, Perez F, Andre J (date unknown). Regional arterial spin labelling hyperperfusion following incomplete hanging. Accepted, .
  • Chen R, Singh G, McNally JS, Palmer CA, de Havenon A (date unknown). Intravascular Lymphoma with Progressive CNS Hemorrhage and Multiple Dissections. (pp. 6134830). Vol. 2020. Accepted, .
  • Dehavenon A (date unknown). CT screening for lung cancer. (pp. 745-6; author reply 746-7). Vol. 356. Accepted, .
  • Kalra L, de Havenon A (date unknown). Mental illness, implicit attitudes, and disparity of carotid revascularization after stroke. Vol. 92, 1033-1034. Accepted, .
  • de Havenon A, Southerland AM (date unknown). In large vessel occlusive stroke, time is brain… but collaterals are time. Vol. 90, 153-154. Accepted, .
  • Menacho ST, Grandhi R, Delic A, Anadani M, Ziai WC, Awad IA, Hanley DF, de Havenon A (date unknown). Impact of Intracranial Pressure Monitor-Guided Therapy on Neurologic Outcome After Spontaneous Nontraumatic Intracranial Hemorrhage. Vol. 30, 105540. Accepted, .
  • McNally JS, Havenon A, Kim SE, Wang C, Wang S, Zabriskie MS, Parker DL, Baradaran H, Alexander MD (date unknown). Rabbit models of intracranial atherosclerotic disease for pathological validation of vessel wall MRI. 1971400920980153. Accepted, .
  • Wong KH, Hu K, Peterson C, Sheibani N, Tsivgoulis G, Majersik JJ, de Havenon AH (date unknown). Diabetic Retinopathy and Risk of Stroke: A Secondary Analysis of the ACCORD Eye Study. Vol. 51, 3733-3736. Accepted, .
  • Medicherla CB, Pauley RA, de Havenon A, Yaghi S, Ishida K, Torres JL (date unknown). Cerebral Venous Sinus Thrombosis in the COVID-19 Pandemic. Vol. 40, 457-462. Accepted, .
  • Zhou E, Lord A, Boehme A, Henninger N, de Havenon A, Vahidy F, Ishida K, Torres J, Mistry EA, Mac Grory B, Sheth KN, Gurol ME, Furie K, Elkind MSV, Yaghi S (date unknown). Risk of Ischemic Stroke in Patients With Atrial Fibrillation After Extracranial Hemorrhage. Vol. 51, 3592-3599. Accepted, .
  • Katsanos AH, Alexandrov AV, Mandava P, Köhrmann M, Soinne L, Barreto AD, Sharma VK, Mikulik R, Muir KW, Rothlisberger T, Grotta JC, Levi CR, Molina CA, Saqqur M, Palaiodimou L, Psaltopoulou T, Vosko MR, Moreira T, Fiebach JB, Rubiera M, Sandset EC, de Havenon A, Kent TA, Alexandrov AW, Schellinger PD, Tsivgoulis G, CLOTBUST-ER Trial Investigators. (date unknown). Pulse pressure variability is associated with unfavorable outcomes in acute ischaemic stroke patients treated with intravenous thrombolysis. Vol. 27, 2453-2462. Accepted, .
  • Guan J, McNally S, de Havenon A, Kalani MYS, Taussky P, Kim S, Park MS (date unknown). High-Resolution Magnetic Resolution Imaging of Intracranial Aneurysms Treated by Flow Diversion. Vol. 10, 69-74. Accepted, .
  • de Havenon AH, Mossa-Basha M, Shah L, Kim SE, Park M, Parker D, McNally S (date unknown). High-Resolution Vessel Wall MRI for the Evaluation of Intracranial Atherosclerotic Disease. Vol. 59, 1193-1202. Accepted, .
  • Bennett A, Wold J, de Havenon A (date unknown). Treatment of Carotid Intramural Thrombus With TPA. Vol. 73, 1496. Accepted, .
  • de Havenon A, Sultan-Qurraie A, Tirschwell D, Cohen W, Majersik J, Andre JB (date unknown). Medial Occipital Lobe Hyperperfusion Identified by Arterial Spin-Labeling: A Poor Prognostic Sign in Patients with Hypoxic-Ischemic Encephalopathy. Vol. 36, 2292-5. Accepted, .
  • de Havenon A, Joos Z, Longenecker L, Shah L, Ansari S, Digre K (date unknown). Posterior reversible encephalopathy syndrome with spinal cord involvement. Vol. 83, 2002-6. Accepted, .
  • Doll ES, Bonkowsky JL, Brown LL, de Havenon AH, Brockmeyer DL, Glasgow TS, Morita DC (date unknown). Chiari I Malformation Causing Developmental Regression in a 4 Month Old. Vol. 1, 2333794X14560819. Accepted, .
  • de Havenon A, Narata AP, Amelot A, Saver JL, Bozorgchami H, Mattle HP, Ribo M, Andersson T, Zaidat OO, ARISE II investigators. (date unknown). Benefit of endovascular thrombectomy for M2 middle cerebral artery occlusion in the ARISE II study. Accepted, .
  • de Havenon A, Chung LS, Smith J, Taylor K, Majersik JJ, Chauhan N (date unknown). Less Experienced Telestroke Consultants Are More Likely to Go On-Camera, but Less Likely to Give tPA. Vol. 2019, 1059369. Accepted, .
  • de Havenon A, Yaghi S, Mistry EA, Delic A, Hohmann S, Shippey E, Stulberg E, Tirschwell D, Frontera JA, Petersen NH, Anadani M (date unknown). Endovascular thrombectomy in acute ischemic stroke patients with COVID-19: prevalence, demographics, and outcomes. Vol. 12, 1045-1048. Accepted, .
  • de Havenon A, Prabhakaran S, Turan T, Gottesman R, Yeatts S, Rost N (date unknown). Is There Equipoise Regarding the Optimal Medical Treatment of Patients with Asymptomatic White Matter Hyperintensities?. Vol. 28, 104371. Accepted, .
  • de Havenon A (date unknown). Blood pressure variability: An emerging target for risk reduction in the setting of hypertensive emergency. Vol. 21, 1693-1694. Accepted, .
  • de Havenon A, Fino NF, Johnson B, Wong KH, Majersik JJ, Tirschwell D, Rost N (date unknown). Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS. Vol. 50, 3170-3176. Accepted, .
  • Mossa-Basha M, Shibata DK, Hallam DK, de Havenon A, Hippe DS, Becker KJ, Tirschwell DL, Hatsukami T, Balu N, Yuan C (date unknown). Added Value of Vessel Wall Magnetic Resonance Imaging for Differentiation of Nonocclusive Intracranial Vasculopathies. Vol. 48, 3026-3033. Accepted, .
  • Anadani M, Lapergue B, Blanc R, Kyheng M, Labreuche J, Machaa MB, Duhamel A, Marnat G, Saleme S, Costalat V, Bracard S, Anxionnat R, Spiotta AM, DeHavenon A, Richard S, Desal H, Mazighi M, Consoli A, Piotin M, Gory B (date unknown). Admission Blood Pressure and Outcome of Endovascular Therapy: Secondary Analysis of ASTER Trial. Accepted, .
  • Medicherla CB, Pauley RA, de Havenon A, Yaghi S, Ishida K, Torres JL (date unknown). Cerebral Venous Sinus Thrombosis in the Coronavirus Disease 2019 Pandemic. Accepted, .
  • Samara VC, de Havenon A (date unknown). Rare case of T-cell lymphoma presenting as acute myelopathy. Vol. 2016. Accepted, .
  • Taussky P, Agnoletto G, Grandhi R, Alexander MD, Wong KH, Albers GW, de Havenon A (date unknown). Prediction of death after endovascular thrombectomy in the extended window: a secondary analysis of DEFUSE 3 ". Accepted, .
  • French KF, Martinez JK, DeHavenon AH et al. (date unknown). Reproducibility of ABC/2 method to determine infarct volume and mismatch percentage with CT perfusion. Vol. 24, 232-7. Accepted, .
  • Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, Snyder T, Berger S, Yang D, Granger A, Morgan N, Patel P, Gutman J, Melmed K, Agarwal S, Bokhari M, Andino A, Valdes E, Omari M, Kvernland A, Lillemoe K, Chou SH, McNett M, Helbok R, Mainali S, Fink EL, Robertson C, Schober M, Suarez JI, Ziai W, Menon D, Friedman D, Friedman D, Holmes M, Huang J, Thawani S, Howard J, Abou-Fayssal N, Krieger P, Lewis A, Lord AS, Zhou T, Kahn DE, Czeisler BM, Torres J, Yaghi S, Ishida K, Scher E, de Havenon A, Placantonakis D, Liu M, Wisniewski T, Troxel AB, Balcer L, Galetta S (date unknown). A Prospective Study of Neurologic Disorders in Hospitalized COVID-19 Patients in New York City. Accepted, .
  • Anadani M, Arthur AS, Alawieh A, Orabi Y, Alexandrov A, Goyal N, Psychogios MN, Maier I, Kim JT, Keyrouz SG, de Havenon A, Petersen NH, Pandhi A, Swisher CB, Inamullah O, Liman J, Kodali S, Giles JA, Allen M, Wolfe SQ, Tsivgoulis G, Cagle BA, Oravec CS, Gory B, De Marini P, Kan P, Rahman S, Richard S, Nascimento FA, Spiotta A (date unknown). Blood pressure reduction and outcome after endovascular therapy with successful reperfusion: a multicenter study. Vol. 12, 932-936. Accepted, .
  • de Havenon A, Muhina HJ, Parker DL, McNally JS, Alexander MD (date unknown). Effect of Time Elapsed since Gadolinium Administration on Atherosclerotic Plaque Enhancement in Clinical Vessel Wall MR Imaging Studies. Vol. 40, 1709-1711. Accepted, .
  • McNally JS, Hinckley PJ, Sakata A, Eisenmenger LB, Kim SE, De Havenon AH, Quigley EP, Iacob E, Treiman GS, Parker DL (date unknown). Magnetic Resonance Imaging and Clinical Factors Associated With Ischemic Stroke in Patients Suspected of Cervical Artery Dissection. Vol. 49, 2337-2344. Accepted, .
  • de Havenon A, Tirschwell D, Majersik JJ, McNally S, Stoddard G, Moore A, Mossa-Basha M (date unknown). Carotid intraplaque hemorrhage on vessel wall MRI does not correlate with TCD emboli monitoring in patients with recently symptomatic carotid atherosclerosis. Vol. 30, 486-489. Accepted, .
  • de Havenon A, Petersen C, Tanana M, Wold J, Hoesch R (date unknown). A pilot study of audiovisual family meetings in the intensive care unit. Vol. 30, 881-3. Accepted, .
  • de Havenon A, Moore A, Sultan-Qurraie A, Majersik JJ, Stoddard G, Tirschwell D (date unknown). Ischemic stroke patients with active malignancy or extracardiac shunts are more likely to have a right-to-left shunt found by TCD than echocardiogram. Vol. 6, 361-4. Accepted, .
  • de Havenon A, Chin B, Thomas KC, Afra P (date unknown). The secret "spice": an undetectable toxic cause of seizure. Vol. 1, 182-6. Accepted, .
  • Anadani M, de Havenon A, Yaghi S, Mehta T, Arora N, Starosciak AK, De Los Rios La Rosa F, Siegler J, Mistry AM, Chitale R, Spiotta AM, Tsivgoulis G, Khatri P, Mistry EA (date unknown). Blood pressure reduction and outcome after endovascular therapy: a secondary analysis of the BEST study. Accepted, .
  • Agarwal S, Scher E, Rossan-Raghunath N, Marolia D, Butnar M, Torres J, Zhang C, Kim S, Sanger M, Humbert K, Tanweer O, Shapiro M, Raz E, Nossek E, Nelson PK, Riina HA, de Havenon A, Wachs M, Farkas J, Tiwari A, Arcot K, Parella DT, Liff J, Wu T, Wittman I, Caldwell R, Frontera J, Lord A, Ishida K, Yaghi S (date unknown). Acute stroke care in a New York City comprehensive stroke center during the COVID-19 pandemic. Vol. 29, 105068. Accepted, .
  • Yaghi S, Mistry E, Liberman AL, Giles J, Asad SD, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Trivedi T, Lord A, Furie K, Keyrouz S, Nouh A, Leon Guerrero CR, de Havenon A, Khan M, Henninger N (date unknown). Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study. Vol. 51, 2724-2732. Accepted, .
  • Sultan-Qurraie A, Witt T, de Havenon A, Ribo M, Zaidat OO (date unknown). SEIMLESS: Simultaneous Extracranial, Intracranial Management of (tandem) LESsions in Stroke. Vol. 11, 879-883. Accepted, .
  • Bennett AE, Wilder MJ, McNally JS, Wold JJ, Stoddard GJ, Majersik JJ, Ansari S, de Havenon A (date unknown). Increased blood pressure variability after endovascular thrombectomy for acute stroke is associated with worse clinical outcome. Vol. 10, 823-827. Accepted, .
  • Kvernland A, Kumar A, Yaghi S, Raz E, Frontera J, Lewis A, Czeisler B, Kahn DE, Zhou T, Ishida K, Torres J, Riina HA, Shapiro M, Nossek E, Nelson PK, Tanweer O, Gordon D, Jain R, Dehkharghani S, Henninger N, de Havenon A, Grory BM, Lord A, Melmed K (date unknown). Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System. Accepted, .
  • de Havenon A, Park M, McNally S (date unknown). Vessel wall MRI of an inflamed aneurysm with atherosclerosis in a patient with ischemic stroke. Vol. 87, 741-2. Accepted, .
  • de Havenon A, Wong KH, Elkhetali A, McNally JS, Majersik JJ, Rost NS (date unknown). Carotid Artery Stiffness Accurately Predicts White Matter Hyperintensity Volume 20 Years Later: A Secondary Analysis of the Atherosclerosis Risk in the Community Study. Vol. 40, 1369-1373. Accepted, .
  • de Havenon A, Majersik JJ, Stoddard G, Wong KH, McNally JS, Smith AG, Rost NS, Tirschwell DL (date unknown). Increased Blood Pressure Variability Contributes to Worse Outcome After Intracerebral Hemorrhage. Vol. 49, 1981-1984. Accepted, .
  • Eisenmenger LB, Aldred BW, Kim SE, Stoddard GJ, de Havenon A, Treiman GS, Parker DL, McNally JS (date unknown). Prediction of Carotid Intraplaque Hemorrhage Using Adventitial Calcification and Plaque Thickness on CTA. Vol. 37, 1496-503. Accepted, .
  • Sharma D, Athiraman U, Sultan-Qurraie A, nair B, Tirschwell D, Ghodke B, de Havenon A, Hallam D, Kim L, Becker K (date unknown). Endovascular Treatmetn of Acute Ischemic Stroke Under General Anesthesia: Predictors of a Good Outcome. Accepted, .
  • de Havenon A, Meyer C, McNally JS, Alexander M, Chung L (date unknown). Subclinical Cerebrovascular Disease: Epidemiology and Treatment. Vol. 21, 39. Accepted, .
  • de Havenon A, Davis G, Hoesch R (date unknown). Splenic rupture associated with primary CMV infection, AMSAN, and IVIG. Vol. 272, 103-5. Accepted, .
  • Yaghi S, Liberman AL, Henninger N, Grory BM, Nouh A, Scher E, Giles J, Liu A, Nagy M, Kaushal A, Azher I, Fakhri H, Espaillat KB, Asad SD, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Trivedi T, Ishida K, Frontera J, Lord A, Furie K, Keyrouz S, de Havenon A, Mistry E, Leon Guerrero CR, Khan M (date unknown). Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation. Vol. 29, 104888. Accepted, .
  • de Havenon A, Khatri P, Prabhakaran S, Yeatts SD, Peterson C, Sacchetti D, Alexander M, Cutting S, Grory BM, Furie K, Liebeskind DS, Yaghi S (date unknown). Hypoperfusion Distal to Anterior Circulation Intracranial Atherosclerosis is Associated with Recurrent Stroke. Vol. 30, 468-470. Accepted, .
  • Zaidat OO, Changal KH, Sultan-Qurraie A, de Havenon A, Calderon VJ, Goins-Whitmore J, Patterson MS, Lin E (date unknown). Diurnal Variations in the First 24/7 Mobile Stroke Unit. Vol. 50, 1911-1914. Accepted, .
  • Athiraman U, Sultan-Qurraie A, Nair B, Tirschwell DL, Ghodke B, Havenon AD, Hallam DK, Kim LJ, Becker KJ, Sharma D (date unknown). Endovascular Treatment of Acute Ischemic Stroke Under General Anesthesia: Predictors of Good Outcome. Vol. 30, 223-230. Accepted, .
  • Ravindra VM, de Havenon A, Gooldy TC, Scoville J, Guan J, Couldwell WT, Taussky P, MacDonald JD, Schmidt RH, Park MS (date unknown). Validation of the unruptured intracranial aneurysm treatment score: comparison with real-world cerebrovascular practice. Vol. 129, 100-106. Accepted, .
  • Mossa-Basha M, de Havenon A, Becker KJ, Hallam DK, Levitt MR, Cohen WA, Hippe DS, Alexander MD, Tirschwell DL, Hatsukami T, Amlie-Lefond C, Yuan C (date unknown). Added Value of Vessel Wall Magnetic Resonance Imaging in the Differentiation of Moyamoya Vasculopathies in a Non-Asian Cohort. Vol. 47, 1782-8. Accepted, .
  • Peckham ME, Anderson JS, Rassner UA, Shah LM, Hinckley PJ, de Havenon A, Kim SE, McNally JS (date unknown). Low b-value diffusion weighted imaging is promising in the diagnosis of brain death and hypoxic-ischemic injury secondary to cardiopulmonary arrest. Vol. 22, 165. Accepted, .
  • de Havenon A, Stoddard G, Saini M, Wong KH, Tirschwell D, Bath P, VISTA-Acute Collaborators. (date unknown). Increased blood pressure variability after acute ischemic stroke increases the risk of death: A secondary analysis of the Virtual International Stroke Trial Archive. Vol. 8, 2048004019856496. Accepted, .
  • de Havenon A, Chung LS, Park M, Mossa-Basha M (date unknown). Intracranial Vessel Wall Imaging with High-Resolution MRI: a review of current indications and future applications. Vol. 2. Accepted, .
  • Alexander MD, de Havenon A, Kim SE, Parker DL, McNally JS (date unknown). Assessment of quantitative methods for enhancement measurement on vessel wall magnetic resonance imaging evaluation of intracranial atherosclerosis. Vol. 61, 643-650. Accepted, .
  • Mossa-Basha M, Hwang WD, De Havenon A, Hippe D, Balu N, Becker KJ, Tirschwell DT, Hatsukami T, Anzai Y, Yuan C (date unknown). Multicontrast high-resolution vessel wall magnetic resonance imaging and its value in differentiating intracranial vasculopathic processes. Vol. 46, 1567-73. Accepted, .
  • de Havenon A, Sultan-Qurraie A, Hannon P, Tirschwell D (date unknown). Development of regional stroke programs. Vol. 15, 544. Accepted, .
  • French KF, Martinez JK, DeHavenon AH, Weathered NR, Grantz M, Smith SM, Wilder M, Rassner UA, Kircher JC, Dewitt LD, Wold JJ, Hoesch RE (date unknown). Reproducibility of ABC/2 method to determine infarct volume and mismatch percentage with CT perfusion. Vol. 24, 232-7. Accepted, .
  • de Havenon A, French K, Ansari S (date unknown). Extensive cortical diffusion restriction in a 50-year-old female with hyperammonemic encephalopathy and status epilepticus. Accepted, .
  • Yaghi S, Khatri P, de Havenon A, Yeatts S, Chang AD, Cutting S, Mac Grory B, Burton T, Jayaraman MV, McTaggart RA, Fiorella D, Derdeyn C, Zaidat OO, Dehkharghani S, Amin-Hanjani S, Furie K, Prahbakaran S, Liebeskind D (date unknown). Peri-procedural stroke or death in stenting of symptomatic severe intracranial stenosis. Vol. 12, 374-379. Accepted, .
  • Yaghi S, Cotsonis G, de Havenon A, Prahbakaran S, Romano JG, Lazar RM, Marshall RS, Feldmann E, Liebeskind DS (date unknown). Poststroke Montreal Cognitive Assessment and Recurrent Stroke in Patients With Symptomatic Intracranial Atherosclerosis. Vol. 29, 104663. Accepted, .
  • de Havenon A, Haynor DR, Tirschwell DL, Majersik JJ, Smith G, Cohen W, Andre JB (date unknown). Association of Collateral Blood Vessels Detected by Arterial Spin Labeling Magnetic Resonance Imaging With Neurological Outcome After Ischemic Stroke. Vol. 74, 453-458. Accepted, .
  • de Havenon A, Majersik JJ, Tirschwell DL, McNally JS, Stoddard G, Rost NS (date unknown). Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics. Vol. 92, e1168-e1175. Accepted, .
  • McNally JS, Kim SE, Mendes J, Hadley JR, Sakata A, De Havenon AH, Treiman GS, Parker DL (date unknown). Magnetic Resonance Imaging Detection of Intraplaque Hemorrhage. Vol. 10, 1-8. Accepted, .
  • Flusty B, de Havenon A, Prabhakaran S, Liebeskind DS, Yaghi S (date unknown). Intracranial Atherosclerosis Treatment: Past, Present, and Future. Vol. 51, e49-e53. Accepted, .
  • de Havenon A, Mlynash M, Kim-Tenser MA, Lansberg MG, Leslie-Mazwi T, Christensen S, McTaggart RA, Alexander M, Albers G, Broderick J, Marks MP, Heit JJ, DEFUSE 3 Investigators. (date unknown). Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome. Vol. 50, 632-638. Accepted, .
  • Chung LS, Tkach A, Lingenfelter EM, Dehoney SB, Rollo J, de Havenon A, DeWitt LD, Grantz MR, Wang H, Wold JJ, Hannon PM, Weathered NR, Majersik JJ (date unknown). Tissue Plasminogen Activator Prescription and Administration Errors within a Regional Stroke System. Vol. 25, 565-71. Accepted, .
  • de Havenon A, Ansari S (date unknown). Combating performance enhancing drug abuse: detection and punishment are not enough. Vol. 3, 51-53. Accepted, .
  • de Havenon A, Bennett A, Stoddard GJ, Smith G, Chung L, O'Donnell S, McNally JS, Tirschwell D, Majersik JJ (date unknown). Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke. Vol. 2, 1-6. Accepted, .
  • de Havenon A, Ney JP, Callaghan B, Delic A, Hohmann S, Shippey E, Esper GJ, Stulberg E, Tirschwell D, Frontera J, Yaghi S, Anadani M, Majersik JJ (date unknown). Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States. Vol. 30, 105535. Accepted, .
  • Mistry EA, Mehta T, Mistry A, Arora N, Starosciak AK, De Los Rios La Rosa F, Siegler JE 3rd, Chitale R, Anadani M, Yaghi S, Khatri P, de Havenon A (date unknown). Blood Pressure Variability and Neurologic Outcome After Endovascular Thrombectomy: A Secondary Analysis of the BEST Study. Vol. 51, 511-518. Accepted, .
  • de Havenon A, Joyce E, Yaghi S, Ansari S, Delic A, Taussky P, Alexander M, Tirschwell D, Grandhi R (date unknown). End-of-Treatment Intracerebral and Ventricular Hemorrhage Volume Predicts Outcome: A Secondary Analysis of MISTIE III. Vol. 51, 652-654. Accepted, .
  • Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al, DEFUSE 3 Investigators (date unknown). Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. (member of DEFUSE 3 investigators). Accepted, .
  • Yaghi S, Dehkharghani S, Raz E, Jayaraman M, Tanweer O, Grory BM, Henninger N, Lansberg MG, Albers GW, Havenon A (date unknown). The Effect of Hyperglycemia on Infarct Growth after Reperfusion: An Analysis of the DEFUSE 3 trial. Vol. 30, 105380. Accepted, .
  • de Havenon A, Bennett A, Stoddard GJ, Smith G, Wang H, Wold J, Chung L, Tirschwell DL, Majersik JJ (date unknown). Increased Blood Pressure Variability Is Associated with Worse Neurologic Outcome in Acute Anterior Circulation Ischemic Stroke. Vol. 2016, 7670161. Accepted, .
  • de Havenon A, Yuan C, Tirschwell D, Hatsukami T, Anzai Y, Becker K, Sultan-Qurraie A, Mossa-Basha M (date unknown). Nonstenotic Culprit Plaque: The Utility of High-Resolution Vessel Wall MRI of Intracranial Vessels after Ischemic Stroke. Vol. 2015, 356582. Accepted, .
  • de Havenon A, French K, Ansari S (date unknown). Extensive cortical diffusion restriction in a 50-year-old female with hyperammonemic encephalopathy and status epilepticus. Vol. 2014, 257094. Accepted, .
  • de Havenon A, Ehrenkranz J (date unknown). A perforated diverticulum in Cushing's disease. Vol. 2, 215-7. Accepted, .
  • Kvernland A, Yaghi S, de Havenon A (date unknown). Letter by Kvernland et al Regarding Article, "Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease: Classification and Clinical Implications". (pp. e436). Vol. 50. Accepted, .
  • de Havenon A, McNally S (date unknown). Response to "High-Resolution Vessel Wall MRI: Appearance of Intravascular Lymphoma Mimics Central Nervous System Vasculitis". (pp. 501). Vol. 26. Accepted, .
  • de Havenon A, Ney JP, Callaghan B, Yaghi S, Majersik JJ (date unknown). Excess neurological death in New York City after the emergence of COVID-19. Accepted, .
  • de Havenon A, Albers GW, Heit JJ (date unknown). Response by de Havenon et al to Letter Regarding Article, "Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome". (pp. e166). Vol. 50. Accepted, .
  • Alexander MD, de Havenon A, Mossa-Basha M, McNally JS (date unknown). How Far Can We Take Vessel Wall MRI for Intracranial Atherosclerosis? The Tissue is Still the Issue. (pp. E30-E31). Vol. 41. Accepted, .
  • Peterson C, Wong KH, Stulberg EL, Taylor K, Cramer SC, de Havenon AH (date unknown). Effect of Premorbid Anxiolytic Medications on Ischemic Stroke Functional Outcome. (pp. STROKEAHA120032812). Accepted, .
  • de Havenon A (date unknown). Monthly contributions to the American Heart Association’s “Blogging Stroke” website. Accepted, .
  • Frontera JA, Rahimian JO, Yaghi S, Liu M, Lewis A, de Havenon A, Mainali S, Huang J, Scher E, Wisniewski T, Troxel AB, Meropol S, Balcer LJ, Galetta SL (date unknown). Treatment with Zinc is Associated with Reduced In-Hospital Mortality Among COVID-19 Patients: A Multi-Center Cohort Study. Accepted, .
  • de Havenon A (date unknown). Appearances on Salt Lake City NBC and ABC affiliates to discuss neurologic illness associated with drug use. Accepted, .
  • Kilburg C, Scott McNally J, de Havenon A, Taussky P, Kalani MY, Park MS (date unknown). Advanced imaging in acute ischemic stroke. (pp. E10). Vol. 42. Accepted, .